Anti-Seizure Drugs & Birth Defects-Topamax & Depakote
Recently, the FDA issued a warning about the epilepsy and migraine drug, Topamax, that if taken during pregnancy could increase risk of birth defects. Depakote, a popular anti-epileptic used to treat seizures, also increases the risk of devastating birth defects if taken while pregnant.
If your child was born with a Cleft Lip or heart defects, limb malformations, craniofacial defects, and persistent pulmonary hypertension in newborns, or other birth defect, an Anti-Seizure Medication such as Topamax or Depakote may be to blame.
In March 2011, the FDA issued a warning that pregnant women who took the epilepsy and migraine drug, Topamax, were at a higher risk of giving birth to a baby with a cleft palate or cleft lip.
In addition, the FDA upgraded Topamax from a Pregnancy Category C drug to a Pregnancy Category D, meaning that there is clear evidence of the risk of birth defects to human fetus.
In addition to these risks, pregnant women who take the drug Topamax are also more likely to give birth to a baby with heart defects, limb malformations, craniofacial defects, and persistent pulmonary hypertension in newborns. (PPHN)
Contact Peterson & Associates, P.C. for a FREE Birth Defect Legal Consultation.
Depakote, manufactured by Abbot Laboratories, was put on the market in 1983. The drug is an anti-epileptic used to treat seizures, bipolar disorder, and migraines. The drug is listed as a Pregnancy Category D drug and has a 4-fold increase in serious birth defects compared to other anticonvulsant drugs. This includes Spina Bifida, Heart Defects, Craniofacial Defects, Cleft Palate, Cleft Lip, and Limb Malformations.
In 2006, Abbott Laboratories added a black box warning about the risks of birth defects if taken during pregnancy. In May 2010, researchers found that the birth defects from Depakote occur as early as the first trimester, before most women even know that they are pregnant.
Unfortunately, Depakote has been used by many pregnant women, resulting in devastating birth defects and malformations.